1.. Introduction {#s1}
================

Dose-finding studies are important for investigating the effect of a compound on a response and have applications in various fields. They are of particular importance in drug development, because marketed doses have to be safe and provide clinically relevant efficacy ([@ASV041C16]). In most of the statistical literature on dose-response studies, a placebo is included as a control group ([@ASV041C2]), and numerous authors have worked on optimal designs in such applications because the use of efficient designs can substantially increase the accuracy of statistical analysis ([@ASV041C10]; [@ASV041C14]; [@ASV041C1]). Dose-response studies that include a marketed drug as an active control are becoming more popular, especially in preparation for active-controlled confirmatory noninferiority trials, where the use of a placebo may be unethical. Hence, there is growing interest in active-controlled studies. For example, [@ASV041C12] investigated the finite-sample properties of maximum likelihood estimators of the target dose in an active-controlled study which achieves the same treatment effect as the active control. However, optimal design problems for such studies have only been considered in one paper ([@ASV041C9]). These authors investigated optimal designs for estimating the target dose under the assumption of a normal distribution with known variances. In particular, they demonstrated the superiority of the optimal designs over standard designs used in pharmaceutical practice.

In this paper we investigate optimal design problems for dose-finding studies with an active control from a more general perspective. First, we consider a general class of optimality criteria. Second, we study exponential families for modelling the distribution of the responses of the new drug and the active control, as in practice the assumption of normally distributed responses is often hard to justify. This enables the design of experiments for active-controlled studies with discrete data, as motivated by the consulting projects described in the next paragraph. Third, we demonstrate that even when the assumption of a normal distribution is justifiable, the estimation of the variances has a nontrivial effect on the optimal designs for an active-controlled study.

The research in the present paper is motivated by two examples where the assumption of normally distributed responses made by [@ASV041C9] is hard to justify. The first example involves a 24-week dose-ranging Phase II study in patients with gouty arthritis to determine the target dose of a compound in preventing signs and symptoms of flares in chronic gout patients starting allopurinol therapy. The primary endpoint is the number of flares occurring per subject within 16 weeks of randomization, which is modelled using a negative binomial distribution for all treatment arms. The second example is a Phase IIb multicentre, randomized, double-blind, active-controlled dose-finding study in the treatment of acute migraine, as measured by the percentage of patients reporting freedom from pain at two hours post-dose.

For brevity, in this paper we restrict our attention to locally optimal designs ([@ASV041C5]). Following [@ASV041C4] and [@ASV041C7], the methodology introduced in the present paper can be further developed to address uncertainty in the preliminary information for the unknown parameters.

2.. Modelling active-controlled studies using exponential families {#s2}
==================================================================

Consider a clinical trial in which patients are treated either with an active control, i.e., a standard treatment administered at a fixed dose level, or with a new drug using different dose levels in order to investigate a dose-response relationship. Let $\documentclass[12pt]{minimal}
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In this section we determine some D-optimal designs under different distributional assumptions for the Michaelis--Menten model $\documentclass[12pt]{minimal}
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4.. Optimal designs for estimating the target dose {#s4}
==================================================

4.1.. AC-optimal designs {#s4a}
------------------------

In this section we investigate the construction of locally optimal designs for estimating the smallest dose of the new compound that achieves the same treatment effect as the active control. We consider a dose range of the form $\documentclass[12pt]{minimal}
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In this subsection we present some examples illustrating different structures of locally AC-optimal designs. We suppose that the Fisher information matrix $\documentclass[12pt]{minimal}
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Explicit expressions for the AC-optimal designs in the $\documentclass[12pt]{minimal}
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We begin with the gouty arthritis clinical trial, for which we use the same prior information as in Example 2. AC-optimal designs under the assumption of normal and negative binomial distributions are shown in Table [2](#ASV041TB2){ref-type="table"}. For instance, under the assumption of normally distributed endpoints, the AC-optimal design allocates almost half of the patients to the dose level $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$101{\cdot }06$\end{document}$ mg and the rest to the active control. In order to compare these results with the standard design introduced in Example 2, we also report values of the efficiency $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$ {\rm eff}_{\rm {ac}}(\xi ,\theta )={\psi (\xi _{\rm {ac}}^{*},\theta )}/{\psi (\xi ,\theta )} , $\end{document}$ where $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\psi (\xi ,\theta )$\end{document}$ is defined in ([19](#ASV041M19){ref-type="disp-formula"}) and $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\xi _{\rm {ac}}^*$\end{document}$ is the locally AC-optimal design. For example, the efficiency of the standard design for estimating the target dose under the assumption of a normal or negative binomial distribution is $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$66\%$\end{document}$ or $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$48\%$\end{document}$, respectively. Table 2.AC-optimal designs in the two examples under different distributional assumptions, together with the efficiencies of the designs used in the studyGouty arthritis exampleAcute migraine example(target dose $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$d^*=100$\end{document}$ mg)(target dose $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$d^*=35{\cdot }6$\end{document}$ mg)DistributionAC-optimal design$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm eff}_\rm {ac}$\end{document}$AC-optimal design$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hbox {eff}_\rm {ac}$\end{document}$Normal$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(101{\cdot }06,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(C,1)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$0{\cdot }66$\end{document}$ $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(35{\cdot }739,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(C,1)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$0{\cdot }48$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$49{\cdot }99\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$50{\cdot }01\%$\end{document}$ $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$0{\cdot }48$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$49{\cdot }99\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$50{\cdot }01\%$\end{document}$nB/Bin$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(5{\cdot }44,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(300,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(C,1)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$0{\cdot }48$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(0,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(200,0)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(C,1)$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$0{\cdot }47$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$7{\cdot }6\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$35{\cdot }6\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$56{\cdot }8\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$7{\cdot }34\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$41{\cdot }95\%$\end{document}$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$50{\cdot }71\%$\end{document}$nB, negative binomial; Bin, binomial.

For the acute migraine clinical trial, we again use the prior information from Example 2. AC-optimal designs for normally and binomially distributed responses are summarized in Table [2](#ASV041TB2){ref-type="table"}. The efficiencies of the standard designs are $\documentclass[12pt]{minimal}
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[Supplementary material available at *Biometrika* online includes further examples and the proof of Theorem 5](http://biomet.oxfordjournals.org/lookup/suppl/doi:10.1093/biomet/asv041/-/DC1).
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The proof of (i) was given in §3. For the remaining cases we restrict ourselves to the Poisson distribution, for which the Fisher information matrix in model ([1](#ASV041M1){ref-type="disp-formula"}) is $\documentclass[12pt]{minimal}
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